NCT02488408
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02488408
Title Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine in Patients With AML
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors BerGenBio AS
Indications
Therapies
Age Groups: adult
Covered Countries USA | NOR | ITA | DEU

Facility Status City State Zip Country Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
Medizinische Hochschule Hannover,Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Hanover Carl-Neuberg-Str 30625 Germany Details
University Medical Center Hamburg Hamburg Hamburg-Eppendorf 20246 Germany Details
Frankfurt Medizinische Klinik II, Hämatologie/Onkologie, Haus 33, 2. OG Frankfurt Theodor-Stern-Kai 60590 Germany Details
Studienzentrale der Hämatologie/Onkologie III, Medizinische Klinik Mannheim Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
Azienda Ospedaliera S Croce E Carle, Via Michele Coppino Cuneo 12100 Italy Details
Ospedale Policlinico San Martino Genoa 16132 Italy Details
Ospedale Lecce - 'V Fazzi' U. O. Ematologia - P. O. Vito Fazz Piazza Muratore, IV piano Polo Oncologico Lecce 73100 Italy Details
Azienda Ospedaliero-Universitaria di Parma Parma 43126 Italy Details
University of Bergen Department of Clinical Science, Translational Hemato-Oncology group, Faculty of Medicine and Dentistry, Haukelands University Hospital Bergen Jonas Lies Vei 5021 Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field